ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Wednesday reported third-quarter net income of $8.8 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Rockville, Maryland-based company said it had net income of 23 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.

The biotechnology company posted revenue of $98.9 million in the period.

Regenxbio shares have fallen 24% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $31.07, a decline of 16% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News